Anirban Maitra: Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAFV600E mCRC

Anirban Maitra

Applications are Open for IDEA Program with Special QI Mentorship Opportunity - ASCO

IDEA Program

Minhua Chu: Rui Therapeutics Completed a Series A Financing Exceeding RMB 200 Million

Minhua Chu, Rui Therapeutics

Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

Razelle Kurzrock: Our Commentary and Implications for Future Precision Studies

Razelle Kurzrock

Oncology News, Insights, Stories by OncoDaily

Top-Paying
Oncolibrary

Top-Paying Oncology Specialties Worldwide in 2025

SIOG
OncoDaily Pulse

SIOG and OncoDaily Announce Strategic Partnership to Advance Global Geriatric Oncology

100 Influential Women in Oncology
Positive

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

Global Voices in Renal Oncology (VIRO) 2025 Comes to a Close: A Global Success Story

Giuseppe Curigliano: How United Efforts Can Truly Advance Cancer Care for Patients Worldwide

Post-Trastuzumab Deruxtecan Outcomes in Metastatic Breast Cancer

Enrique Soto: The New ASCO Global Geriatric Oncology Guidelines

Mary Pasquinelli: Proud to Be Elected to the IASLC Board of Directors

Naveen Pemmaraju: Final Paper on Tagraxofusp in Chronic Myelomonocytic Leukemia Is Out

Rachel Riechelmann: Common Sense Oncology Symposium at ESMO Congress 2025 Berlin

awards
awards
awards
awards
awards
awards

Voices
Giuseppe Curigliano

Giuseppe Curigliano: KSMO-ESMO Collaboration Reinforces Global Cancer Research and Care

Michael Sapienza: Stigma and Silence Cost Lives - It’s Time to Confront Them

Exploring the Link Between Hepatitis and Cancer - European Cancer Organisation

Shine in Gold and Spread Awareness of Childhood Cancer - SIOP Europe

Clara Llamedo: The Very First ESC Certification in Cardio-Oncology Has Been Launched

Powerful Reminder of What True Collaboration Can Achieve - City Cancer Challenge

Richard Sullivan: Global Health Funding Is Vaporising, Cancer Research Under Threat

Celebrities and Cancer

OncoCalendar

The Comprehensive Online Course on Oncology Research and Clinical Trials by ESO

European School of Oncology

26 Sep
Comprehensive Online Course

The Comprehensive Online Course on Oncology Research and Clinical Trials by ESO

European School of Oncology

19 Sep
Comprehensive Online Course

Hack4Hope 2025: 2nd Edition

Paris-Saclay Cancer Cluster (PSCC)

03 Dec
Hack4Hope 2025

The 47th ESPEN Congress

European Society for Clinical Nutrition and Metabolism (ESPEN)

13 Sep
The 47th ESPEN Congress

The 7th CUHK Sarcoma Masterclass

CUHK Medical Centre

20 Sep
The 7th CUHK Sarcoma Masterclass

Immune-oncology
Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

10 Must-Read Posts in Immuno-Oncology This Week

LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC

Top Immunotherapy Trials in Head and Neck and Endocrine Cancers to Watch at ESMO 2025

10 Must-Read Posts in Immuno-Oncology This Week

BOT/BAL Advancements, BATTMAN Trial, FDA Approval Challenges and Key Highlights from Agenus Stakeholder Briefing

ROWAN Study of TheraSphere with Durvalumab and Tremelimumab in HCC Completed Enrollment

OncoGrants
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

National Cancer Institute Youth Enjoy Science Research Education Program

National Cancer Institute Youth Enjoy Science Research Education Program

Innovative Biospecimen Science Technologies for Basic & Clinical Cancer Research

Innovative Biospecimen Science Technologies for Basic & Clinical Cancer Research

Addressing Barriers to Healthcare Transitions for Survivors of Childhood & Adolescent Cancers

Addressing Barriers to Healthcare Transitions for Survivors of Childhood & Adolescent Cancers

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care
Oncologist Near Me

Oncologist Near Me - Guillermo Chantada: A Leading Expert in Pediatric Oncology

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologist
Aparna Parikh

Aparna Parikh

Boston, USA
Rachna Shroff

Rachna Shroff

Tucson, USA
Gregory Kalemkerian

Gregory Kalemkerian

Ann Arbor, USA
Hagop-Kantarjian

Hagop Kantarjian

Houston, USA
Sarkis Meterissian

Sarkis Meterissian

Montreal, Canada
Florian Lordick

Florian Lordick

Leipzig, Germany
LIdia Schapira

Lidia Schapira

Stanford, USA
Matti Aapro

Matti Aapro

Genolier, Switzerland
Rob Pieters

Rob Pieters

Utrecht, Netherlands
Giuseppe Curigliano

Giuseppe Curigliano

Milan, Italy
Yelena Janjigian

Yelena Janjigian

New York, USA

Oncology Drugs
Zongertinib (Hernexeos)

Zongertinib (Hernexeos) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More

Unreleased Decision Letters From 2024–2025 Now Available - FDA

Dordaviprone (Modeyso) 2025: What patients need to know?

The FDA Has Granted Accelerated Approval to Zongertinib - The Babak Lab

Dordaviprone (Modeyso) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and more

Zanidatamab (Ziihera): Patient Guide for 2025

Zanidatamab (Ziihera) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More

OncoDaily Magazine

awards
awards
awards
awards
awards
awards

New Paper Alert
Nationwide Real-World Evidence of Immunotherapy in Armenia

Nationwide Real-World Evidence of Immunotherapy in Armenia

Amivantamab–Lazertinib Improves Survival Over Osimertinib in EGFR-Mutated NSCLC

Amivantamab–Lazertinib Improves Survival Over Osimertinib in EGFR-Mutated NSCLC

Treatment Abandonment

Childhood Cancer in Pakistan: Factors Driving Treatment Abandonment at a Tertiary Center

Melanoma

Evolution of the treatment of metastatic cutaneous melanoma over the past 5 decades

Her2 low TNBC

New Paper Alert: HER2-Low Triple-Negative Breast Cancer in Asian Women. Clinicopathologic and Genomic Insights

BRCA 1/2 mutation

New Paper Alert: BRCA1/2 Mutations and RB1 Alterations Predict Poorer Outcomes With Endocrine Therapy ± CDK4/6 Inhibitors in HR+/HER2– Breast Cancer

OncoDaily Medical Journal

Precision Oncology

10.69690/ODMJ-019-0829-4588

Harnessing Real-World Evidence to Support Precision Oncology
Opinion

Pediatric Oncology

10.69690/ODMJ-001-0829-4568

Identifying the Factors Contributing to Treatment Abandonment in Childhood Cancers at a Tertiary Care Hospital in Pakistan
Original Research

Global Oncology

10.69690/ODMJ-001-0811-4701

The Role of National and Regional Cancer Registries in Shaping Cancer Care Policies
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0809-4599

Survival Outcomes of Wilms' Tumor in Pediatric Patients Treated at KFMC: A Retrospective Study of 15 years from 2007-2022
Original Research

GI Oncology

10.69690/ODMJ-018-0425-4320

Colorectal Cancer in Latin America: Quick Comment
Commentaries

GI Oncology

10.69690/ODMJ-002-0701-4309

Current Perspective of Gastro-intestinal Cancer in Guatemala
Review/Meta-Analysis

Pediatric Oncology

10.69690/ODMJ-003-0520-4233

In the Crossfire: A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group
Editorial

Pediatric Oncology

10.69690/ODMJ-018-0425-4062

CD19+ CAR-T Therapy for Relapsed or Refractory B-ALL and Burkitt Lymphoma in Children and Young Adults in the Republic of Belarus
Abstracts